MunozCFloreenAGareyC, et al. Misdiagnosis and diabetic ketoacidosis at diagnosis of type 1 diabetes: patient and caregiver perspectives. Clin Diab. 2019;37(3):276-281. doi:10.2337/cd18-0088
4.
UmpierrezGESmileyDKitabchiAE.Ketosis-prone type 2 diabetes mellitus. Ann Int Med. 2006;144:350-357.
5.
BenoitSRZhangYGeissLSGreggE.Trends in diabetic ketoacidosis hospitalizations and in-hospital mortality – United States, 2000–2014. MMWR. 2018;67(12):362-365.
6.
BenoitSHoraIPasquelF, et al. Trends in emergency department visits and inpatient admissions for hyperglycemia crises in adults with diabetes in U.S. 2006 – 2015. Diabetes Care. 2020;43(5):1057-1064. doi:10.2337/dc19-2449
7.
AyeTMazaikaPKMaurasN, et al. The impact of early ketoacidosis on the developing brain. Diabetes Care. 2019;42(3):443-449. doi:10.2337/dc18-1405
8.
HammanRFBellRADabeleaD, et al. The SEARCH for diabetes in youth study: rationale, findings and future directions. Diabetes Care. 2014;37(12):3336-3344. doi:10.2337/dc14-0574
9.
RosenstockJFerranniniE.Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors. Diabetes Care. 2015;38:1638-1642. doi:10.2337/dc15-1380
10.
PetersALBuschurEOBuseJB, et al. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015;38(9):1687-1693. doi:10.2337/dc15-0843
11.
NyenweEAKitabchiAE.The evolution of diabetic ketoacidosis: an update of its etiology, pathogenesis and management. Metabolism. 2016;65(4):507-521. doi:10.1016/j.metabol.2015.12.007
12.
KitabchiAEUmpierrezGEMilesJMFisherJN.Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2009;32(7):1335-1343. doi:10.2337/dc09-9032
13.
DanneTGargSPetersAL, et al. International consensus on risk of management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors. Diabetes Care. 2019;42(6):1147-1154. doi:10.2337/dc18-2316
